Katherine Kent1, Karen Charlton2, Steven Roodenrys3, Marijka Batterham4, Jan Potter5, Victoria Traynor6, Hayley Gilbert3, Olivia Morgan3, Rachelle Richards3. 1. School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW, 2522, Australia. kc582@uow.edu.au. 2. School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW, 2522, Australia. 3. School of Psychology, Faculty of Social Sciences, University of Wollongong, Wollongong, NSW, Australia. 4. Statistical Consulting Service, University of Wollongong, Wollongong, NSW, Australia. 5. Division of Aged Care and Rehabilitation, Illawarra Shoalhaven Local Health District, Wollongong Hospital, Wollongong, NSW, Australia. 6. School of Nursing, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW, Australia.
Abstract
PURPOSE: Dietary flavonoids, including anthocyanins, may positively influence cognition and may be beneficial for the prevention and treatment of dementia. We aimed to assess whether daily consumption of anthocyanin-rich cherry juice changed cognitive function in older adults with dementia. Blood pressure and anti-inflammatory effects were examined as secondary outcomes. METHODS: A 12-week randomised controlled trial assessed cognitive outcomes in older adults (+70 year) with mild-to-moderate dementia (n = 49) after consumption of 200 ml/day of either a cherry juice or a control juice with negligible anthocyanin content. Blood pressure and inflammatory markers (CRP and IL-6) were measured at 6 and 12 weeks. ANCOVA controlling for baseline and RMANOVA assessed change in cognition and blood pressure. RESULTS: Improvements in verbal fluency (p = 0.014), short-term memory (p = 0.014) and long-term memory (p ≤ 0.001) were found in the cherry juice group. A significant reduction in systolic (p = 0.038) blood pressure and a trend for diastolic (p = 0.160) blood pressure reduction was evident in the intervention group. Markers of inflammation (CRP and IL-6) were not altered. CONCLUSION: Inclusion of an anthocyanin-rich beverage may be a practical and feasible way to improve total anthocyanin consumption in older adults with mild-to-moderate dementia, with potential to improve specific cognitive outcomes.
RCT Entities:
PURPOSE: Dietary flavonoids, including anthocyanins, may positively influence cognition and may be beneficial for the prevention and treatment of dementia. We aimed to assess whether daily consumption of anthocyanin-rich cherry juice changed cognitive function in older adults with dementia. Blood pressure and anti-inflammatory effects were examined as secondary outcomes. METHODS: A 12-week randomised controlled trial assessed cognitive outcomes in older adults (+70 year) with mild-to-moderate dementia (n = 49) after consumption of 200 ml/day of either a cherry juice or a control juice with negligible anthocyanin content. Blood pressure and inflammatory markers (CRP and IL-6) were measured at 6 and 12 weeks. ANCOVA controlling for baseline and RMANOVA assessed change in cognition and blood pressure. RESULTS: Improvements in verbal fluency (p = 0.014), short-term memory (p = 0.014) and long-term memory (p ≤ 0.001) were found in the cherry juice group. A significant reduction in systolic (p = 0.038) blood pressure and a trend for diastolic (p = 0.160) blood pressure reduction was evident in the intervention group. Markers of inflammation (CRP and IL-6) were not altered. CONCLUSION: Inclusion of an anthocyanin-rich beverage may be a practical and feasible way to improve total anthocyanin consumption in older adults with mild-to-moderate dementia, with potential to improve specific cognitive outcomes.
Authors: Robert Krikorian; Tiffany A Nash; Marcelle D Shidler; Barbara Shukitt-Hale; James A Joseph Journal: Br J Nutr Date: 2009-12-23 Impact factor: 3.718
Authors: Robert Krikorian; Erin L Boespflug; David E Fleck; Amanda L Stein; Jolynne D Wightman; Marcelle D Shidler; Sara Sadat-Hossieny Journal: J Agric Food Chem Date: 2012-04-09 Impact factor: 5.279
Authors: Marianne J Engelhart; Mirjam I Geerlings; Annemieke Ruitenberg; John C van Swieten; Albert Hofman; Jacqueline C M Witteman; Monique M B Breteler Journal: JAMA Date: 2002-06-26 Impact factor: 56.272
Authors: John E Lewis; Jillian Poles; Delaney P Shaw; Elisa Karhu; Sher Ali Khan; Annabel E Lyons; Susana Barreiro Sacco; H Reginald McDaniel Journal: J Clin Transl Res Date: 2021-08-04
Authors: Catherine P Bondonno; Nicola P Bondonno; Frederik Dalgaard; Kevin Murray; Samantha L Gardener; Ralph N Martins; Stephanie R Rainey-Smith; Aedín Cassidy; Joshua R Lewis; Kevin D Croft; Cecilie Kyrø; Gunnar Gislason; Augustin Scalbert; Anne Tjønneland; Kim Overvad; Jonathan M Hodgson Journal: Alzheimers Dement (N Y) Date: 2021-05-13